11 August 2020: Original Paper
Tracheostomy Post Liver Transplant: Predictors, Complications, and Outcomes
Ryan C. Graham 1ABCEF , Weston J. Bush 2BCD , Jeffrey S. Mella 3AB , Jonathan A. Fridell 4DE , Burcin Ekser 4DE , Plamen Mihaylov 4DE , Chandrashekhar A. Kubal 4DE , Richard S. Mangus 4ABCDEF*DOI: 10.12659/AOT.920630
Ann Transplant 2020; 25:e920630
Table 3 Case control analysis of muscle mass in patients with tracheostomy and matched controls without tracheostomy*.
| No tracheostomy (controls) | Tracheostomy (cases) | p-Value | |
|---|---|---|---|
| Age (median (SD)) | 53 (12) | 58 (11) | |
| Model for end-stage liver disease score (SD) | 22 (9) | 22 (9) | 0.78 |
| Body mass index (median (SD)) | 27.7 (6) | 26.5 (5) | 0.05 |
| Pack-years smoking (mean, median SD) | 13.0 (18) | 12, 3 (20) | 0.82 |
| ** | |||
| Psoas index group median | 4.6 | 3.2 | |
| Psoas index matched difference | −39% (120) | ||
| Biochemical markers of nutrition | |||
| Serum albumin level (median SD) | 3.0 (0.7) | 2.9 (0.8) | 0.97 |
| Serum protein level (median SD) | 6.5 (0.9) | 6.4 (1.2) | 0.97 |
| *** | |||
| Forced vital capacity (FVC, % of predicted (SD)) | 88% (19) | 81% (20) | 0.03 |
| Forced expiratory volume in 1 second | |||
| (FEV1,% of predicted (SD)) | 83% (18) | 76% (18) | 0.02 |
| FEV1/FVC (% of predicted (SD)) | 76% (7) | 75% (8) | 0.45 |
| Length of hospital stay (median (SD)) | 10 (41) | 45 (64) | |
| 1-year patient survival | 94% | 65% | |
| * Cases and controls matched for age, gender, MELD score and year of transplant; ** 2 patients in the tracheostomy group did not have CT or MRI available for review; *** 15 patients in the tracheostomy group and 8 patients in the control group did not have PFTs available. | |||